Capsule Announces Reseller Agreement with InterSystems

InterSystemsCapsule Technologie, the leading global provider of medical device integration solutions, has signed a reseller agreement with InterSystems, a global leader in software for connected healthcare. Under the terms of the agreement, InterSystems will be authorized to resell Capsule's SmartLinx Medical Device Information System® (MDIS). The two companies' partnership stems from a shared vision of connected care and strong global market presence.

Capsule's SmartLinx MDIS is healthcare's first integrated system to enable hospitals and healthcare delivery organizations to increase efficiency and help improve patient care delivery through the capture of medical device data and context directly at the point of care. The system consolidates clinical workflow and puts data to work by integrating it with both electronic medical records and intelligent systems to drive informed clinical and operational decisions. Connectivity and data capture are achieved through integrated hardware and/or software solutions that meet the requirements of virtually any healthcare environment.

InterSystems TrakCare® is a unified healthcare information system that provides a comprehensive set of administrative and advanced clinical capabilities to rapidly enable a shared electronic medical record (EMR) across care settings. The partnership with Capsule will enable TrakCare customers to capture real-time observation data in ICU and operating theatres and store the data in the patient's EMR.

Both companies share a global presence while providing pre-configured solutions to meet the needs of local markets. "Establishing this partnership with Capsule is an exciting opportunity for both companies," said Christine Chapman, Vice President, TrakCare, at InterSystems. "The bundling of Capsule’s MDIS solution with TrakCare® will enable customers to seamlessly connect devices and make that data immediately available in the TrakCare EMR, triggering decision support, workflows and alerts for improved quality of care."

"Like InterSystems, Capsule works closely with our partners to localize our market strategy," said Didier Argenton, Capsule's Vice President of International Sales. "This agreement will facilitate entry into new markets and will contribute significantly in developing our presence worldwide."

Related news articles:

About Capsule
Capsule is the leading global provider of medical device integration solutions for hospitals and healthcare organizations. Capsule's SmartLinxMedical Device Information System® (MDIS) increases efficiency and helps improve patient care through the systematic real-time capture of patient vitals at the point-of-care and the delivery of those data to hospital electronic medical records, other information systems and third party mobile solutions. Capsule's solutions are flexible and scalable, offering a variety of deployment options to meet the needs of any healthcare delivery organization. Founded in 1997, the Company has established strong partnerships with leading medical device manufacturers and installed enterprise-wide solutions in over 1,800 hospitals in 38 countries.

About InterSystems
InterSystems develops advanced software technologies that enable breakthroughs. With a passion for excellence and a focus on client success, InterSystems provides data management, strategic interoperability, and analytics platforms used in healthcare, financial services, government, and other industries. In selected countries, InterSystems also offers unified healthcare applications, based on its core technologies, that deliver on the promise of connected healthcare. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its products are used daily by millions of people in more than 100 countries.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...